

浏览全部资源
扫码关注微信
1.河南省中医院,郑州 450002
2.河南中医药大学 第一附属医院,郑州 450008
3.河南中医药大学 第三附属医院,郑州 450003
Received:21 October 2020,
Published Online:18 November 2020,
Published:20 September 2021
移动端阅览
姚玉红,张华,李健等.扶元散加减联合耳穴压豆治疗Ⅱ,Ⅲ期糖尿病肾病的疗效及对血清JAK/STAT信号通路的影响[J].中国实验方剂学杂志,2021,27(18):80-87.
YAO Yu-hong,ZHANG Hua,LI Jian,et al.Effect of Modified Fuyuanwan Combined with Auricular Acupressure Bean on Stage Ⅱ, Ⅲ Diabetic Nephropathy and Its Effect on Serum JAK/STAT Signaling Pathway[J].Chinese Journal of Experimental Traditional Medical Formulae,2021,27(18):80-87.
姚玉红,张华,李健等.扶元散加减联合耳穴压豆治疗Ⅱ,Ⅲ期糖尿病肾病的疗效及对血清JAK/STAT信号通路的影响[J].中国实验方剂学杂志,2021,27(18):80-87. DOI: 10.13422/j.cnki.syfjx.20210226.
YAO Yu-hong,ZHANG Hua,LI Jian,et al.Effect of Modified Fuyuanwan Combined with Auricular Acupressure Bean on Stage Ⅱ, Ⅲ Diabetic Nephropathy and Its Effect on Serum JAK/STAT Signaling Pathway[J].Chinese Journal of Experimental Traditional Medical Formulae,2021,27(18):80-87. DOI: 10.13422/j.cnki.syfjx.20210226.
目的
2
观察扶元散加减联合耳穴压豆治疗Ⅱ,Ⅲ期糖尿病肾病的疗效及对血清酪氨酸激酶/信号转导子及转录激活因子(JAK/STAT)信号通路的影响。
方法
2
180例患者随机分为对照组和观察组,各90例。两组分别给予氯沙坦钾,扶元散加减联合耳穴压豆,疗程均为12周。治疗前后分别观察两组肾功能指标血尿素氮(BUN),肌酐(SCr),尿白蛋白排泄率(UAER),24 h尿蛋白定量(24 h Upor);肠道菌群(疣微菌门菌、硬壁菌门菌、脱铁杆菌门菌、变形菌门菌)相对丰度;氧化应激指标晚期蛋白氧化产物(AOPPs),活性氧(ROS),谷胱甘肽过氧化物酶(GSH-Px),总超氧化物歧化酶(TSOD);肾血流指标舒张末期的血流速度(EDV),肾段动脉的收缩期峰值(PSV),搏动指数(PI),血流阻力指数(RI);JAK/STAT信号通路JAK,磷酸化JAK(p-JAK),STAT,磷酸化STAT(p-STAT)水平。观察两组安全性,治疗后及随访1年,2年临床疗效。
结果
2
治疗后及随访1年,2年,观察组总有效率分别为97.8%(87/89),81.6%(71/87),59.8%(49/82),明显高于同期对照组的79.3%(69/87),57.8%(48/83),37.2%(29/78)(
χ
2
=4.016,
χ
2
=4.503,
χ
2
=4.769,
P
<
0.05)。治疗后与对照组比较,观察组BUN,SCr,UAER,24 h Upor,硬壁菌门菌,脱铁杆菌门菌,变形菌门菌,AOPPs,ROS,PI,RI,p-JAK,p-STAT3明显降低(
P
<
0.05,
P
<
0.01),疣微菌门菌,GSH-Px,TSOD,JAK,STAT3明显升高(
P
<
0.05,
P
<
0.01),EDV,PSV明显加快(
P
<
0.05,
P
<
0.01)。观察组不良反应发生率1.1%(1/89),低于对照组的13.8%(12/87)(
χ
2
=5.127,
P
<
0.05)。
结论
2
扶元散加减联合耳穴压豆可明显改善Ⅱ,Ⅲ期糖尿病肾病的临床疗效,其作用机制可能与调节血清JAK/STAT信号通路有关。
Objective
2
To observe the therapeutic effect of modified Fuyuanwan combined with auricular acupressure bean on stage Ⅱ, Ⅲ diabetic nephropathy and its effect on serum janus kinase (JAK)/ signal transducer and activator of tranions (STAT) signaling pathway.
Method
2
A total of 180 cases were randomly divided into control group and observation group, 90 cases in each group. Losartan potassium, modified Fuyuanwan combined with auricular acupressure bean were given respectively for 12 weeks. Renal function indexes [blood urea nitrogen (BUN), serum creatinine (SCr), urinary albumin excretion rate (UAER), 24 h urinary protein quantitative (24 h Upor)], relative abundance of intestinal flora (verruca microflora, scleriobacteriae, deferribacter, proteobacteria), oxidative stress indicators [advanced oxidation protein products (AOPPs), reactive oxygen species (ROS), glutathione peroxidase (GSH-Px), total superoxide dismutase (TSOD)], renal blood flow index [end-diastolic blood flow velocity (EDV), peak systolic value (PSV), pulse index (PI), blood flow resistance index (RI)], JAK/STAT signaling pathway [JAK, phosphorylated JAK (p-JAK), STAT, phosphorylated STAT (p-STAT) were observed before and after treatment. The safety indexes of two groups were evaluated after treatment. The efficacy was observed after treatment and followed up for 1 years and 2 years.
Result
2
After treatment and follow-up for 1, 2 years, the total effective rates of patients in observation group were 97.8% (87/89), 81.6% (71/87), 59.8% (49/82), respectively, observation group which were significantly higher than those in control group of 79.3%(69/87),57.8%(48/83),37.2%(29/78) (
χ
2
=4.016,
χ
2
=4.503,
χ
2
=4.769,
P
<
0.05). Compared with control group after treatment, UAER, BUN, SCr, 24 h Upor, firmicutes, actinobacillus, proteobacteria, AOPPs, ROS, PI, RI, p-JAK, p-STAT3 in observation group were significantly decreased (
P
<
0.05,
P
<
0.01), microflora verruca, GSH-PX, TSOD, JAK, STAT3 were significantly increased (
P
<
0.05,
P
<
0.01), EDV and PSV were significantly accelerated (
P
<
0.05,
P
<
0.01). The incidence of adverse reactions was 1.1% (1/89) in observation group, lower than 13.8% (12/87) in control group (
χ
2
=5.127,
P
<
0.05).
Conclusion
2
Modified Fuyuanwan combined with auricular acupressure bean can significantly improve the curative effect of stage Ⅱ, Ⅲ diabetic nephropathy, and its mechanism of action may be related to the serum JAK/STAT signaling pathway.
XU W C , QIAN G , LIU A Q , et al . Urinary extracellular vesicle: a potential source of early diagnostic and therapeutic biomarker in diabetic kidney disease [J]. Chinese Med J , 2018 , 131 ( 11 ): 1357 - 1364 .
CHIU P F , SU S L , TSAI C C , et al . Cyclophilin A and CD147 associate with progression of diabetic nephropathy [J]. Free Radic Res , 2018 , 52 ( 11/12 ): 1456 - 1463 .
CHEN H , LI H . Clinical implication of cystatin C and β 2 -microglobulin in early detection of diabetic nephropathy [J]. Clin Lab , 2017 , 63 ( 2 ): 241 - 247 .
RAN J , ZHU P P , ZHONG J , et al . LncRNA KCNQ1OT1 affects cell proliferation, apoptosis and fibrosis through regulating miR-18b-5p/SORBS2 axis and NF- κ B pathway in diabetic nephropathy [J]. Diab Metab Synd , 2020 , 12 ( 1 ): 2549 - 2550 .
MOGENSEN C E , SCHMITZ A , CHRISTENSEN C K . Comparative renal pathophysiology relevant to IDDM and NIDDM patients [J]. Diab Metab Rev , 1988 , 4 ( 5 ): 453 - 456 .
中华医学会糖尿病学分会微血管并发症学组 . 糖尿病肾病防治专家共识(2014年版) [J]. 中华糖尿病杂志 , 2014 , 6 ( 11 ): 792 - 801 .
中华中医药学会 . 中医内科常见病诊疗指南 [M]. 北京 : 中国中医药出版社 , 2008 : 93 - 94 .
杜红玲 . 耳穴压豆配合中药灌肠治疗糖尿病肾病的护理干预 [J]. 糖尿病新世界 , 2019 , 22 ( 5 ): 123 - 124 .
许祯 , 倪雅丽 , 肖曼 , 等 . 缬沙坦灌胃糖尿病肾病小鼠肠道菌群多样性观察 [J]. 山东医药 , 2019 , 59 ( 6 ): 42 - 45 .
KERI K C , SAMJI N S , BLUMENTHAL S . Diabetic nephropathy: newer therapeutic perspectives [J]. J Commun Hosp Intern Med Perspect , 2018 , 8 ( 4 ): 200 - 207 .
DAMILOLA A O , KAYODE O K , TEMITOPE C A , et al . Bridelia ferruginea benth leaves attenuates diabetes nephropathy in STZ-induced rats via targeting NGAL/KIM-1/cystatin c gene [J]. Clin Phytos , 2020 , 6 ( 1 ): 20 - 26 .
HALA E Z , RASHA A G , MAHMOUD S , et al . Synchronized stability indicating RP-LC methods for determination of metolazone with losartan potassium or spironolactone in presence of their degradation products [J]. J Liq Chrom Relat Techn , 2020 , 43 ( 13/14 ): 474 - 481 .
赵维 , 吴广礼 . 补气类单味中药及其提取物防治急性肾损伤研究进展 [J]. 解放军医药杂志 , 2016 , 28 ( 4 ): 109 - 113 .
黄佳颖 , 蔡忠云 , 史静卉 . 耳穴治疗糖尿病的临床研究进展 [J]. 糖尿病新世界 , 2017 , 20 ( 23 ): 188 - 190 .
YU D , SHANG J , CAI Y , et al . A low-cost laboratory-based method for predicting newly diagnosed biopsyproven diabetic nephropathy in people with type 2 diabetes [J]. Diab Med , 2020 , 37 ( 10 ): 1728 - 1736 .
ZHANG S F , LI X , LIANG R F , et al . Baicalin suppresses renal fibrosis through microRNA-124/TLR4/NF- κ B axis in streptozotocin-induced diabetic nephropathy mice and high glucose-treated human proximal tubule epithelial cells [J]. J Phys Biochem , 2020 , 76 ( 3 ): 407 - 416 .
XIONGY C , ZHU W , XU Q , et al . Sleeve gastrectomy attenuates diabetic nephropathy by upregulating nephrin expressions in diabetic obese rats [J]. Obesit Surg , 2020 , 30 ( 4 ): 2893 - 2904 .
许祯 , 倪雅丽 , 肖曼 , 等 . 缬沙坦灌胃糖尿病肾病小鼠肠道菌群多样性观察 [J]. 山东医药 , 2019 , 59 ( 6 ): 42 - 45 .
MOHAN T , KISHORE K N , DIVYA B R , et al . Role of Nrf2 dysfunction in the pathogenesis of diabetic nephropathy: therapeutic prospect of epigallocatechin-3-gallate [J]. Free Rad Biol Med , 2020 , 160 ( 7 ): 227 - 238 .
DU L , WANG J , CHEN Y B , et al . Novel biphenyl diester derivative AB-38b inhibits NLRP3 inflammasome through Nrf2 activation in diabetic nephropathy [J]. Cell Biolo Toxico , 2020 , 36 ( 2 ): 243 - 260 .
LI X , ZHANG T , GENG J , et al . Advanced oxidation protein products promote lipotoxicity and tubulointerstitial fibrosis via CD36/ β -catenin pathway in diabetic nephropathy [J]. Antiox Redo Sign , 2019 , 31 ( 7 ): 521 - 538 .
WANG L , LI X Y , DONG Y Y , et al . Effects of cytotoxic t lymphocyte-associated antigen 4 immunoglobulin combined with microbubble-mediated irradiation on hemodynamics of the renal artery in rats with diabetic nephropathy [J]. Ultras Med Biolo , 2020 , 46 ( 3 ): 703 - 711 .
IBRAHIM S A , SALAMA M A , SELIMA E , et al . Sitagliptin and tofacitinib ameliorate adjuvant induced arthritis via modulating the cross talk between JAK/STAT and TLR-4/NF- κ B signaling pathways [J]. Life Sci , 2020 , 260 ( 8 ): 118261 .
0
Views
25
下载量
1
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution
京公网安备11010802024621